Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
Prostin E2 Vaginal Tablets 3mg.
| Pharmaceutical Form |
|---|
|
Vaginal tablet. White, biconvex, oblong tablet, embossed with Upjohn 715 on one side and plain on the other. |
Each tablet contains 3 mg dinoprostone.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dinoprostone |
|
| List of Excipients |
|---|
|
Lactose |
Amber glass bottle with screw cap and tac seal. Each bottle contains a desiccant capsule and 4 tablets.
Aluminium foil strip of 4 tablets, each box containing 4 or 8 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
PL 00057/1516
Date of first authorisation: 15 March 1982
Date of last renewal: 28 October 2004
| Drug | Countries | |
|---|---|---|
| PROSTIN E2 | Austria, Canada, Cyprus, Hong Kong, Croatia, Ireland, Israel, Malta, Netherlands, New Zealand, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
